Andrew Getahun

8PUBLICATIONS
11CO-AUTHORS
AutoimmunityCellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 07, 2026
Lyn governs the establishment and maintenance of B cell anergy by suppressing PI3K signaling.

Brigita E Fiske, Scott M Wemlinger, Bergren W Crute

|Feb 14, 2024
Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help.

Brigita E Fiske, Andrew Getahun

|Feb 07, 2023
Failed down-regulation of PI3K signaling makes autoreactive B cells receptive to bystander T cell help.

Brigita E Fiske, Andrew Getahun

|Mar 24, 2022
Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model.

Scott M Wemlinger, Chelsea R Parker Harp, Bo Yu

|Feb 07, 2022
Role of inhibitory signaling in peripheral B cell tolerance.

Andrew Getahun

|May 12, 2019
A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.

S Elizabeth Franks, Andrew Getahun, John C Cambier

Pageof 2